EKF Diagnostics Holdings plc provides financial guidance for the year ended December 31, 2014. The company now expects results for the year ended 31 December 2014 to be at the higher end of previous management guidance, with unaudited revenues of around £40.1 million, a 26% improvement on the previous year revenue of £31.8 million despite revenues being impacted negatively by exchange rate differences of £2.6 million. Unaudited adjusted EBITDA is expected to be up 31% to £6.3 million compared to £4.8 million reported in the same period last year.

For the second half year, the company has reported revenue of £23.3 million, up 38% against the same period in 2013, and a 39% improvement on the previous half 2014. Underlying organic revenues accounted for £33.6 million of total revenues which represented 6% organic growth year-on-year.